Venous Thromboembolism Prophylaxis After Major Orthopaedic Surgery: A Pooled Analysis of Randomized Controlled Trials

Journal of Arthroplasty

Volumn 24, Issue 6 SUPPL., 2009, Pages 77-83

  Brown, Greg A ^a,b  

^a PARK NICOLLET INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

orthopaedic surgery; pooled rates; venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; PENTASACCHARIDE; PLACEBO; WARFARIN;

ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HIP FRACTURE; HUMAN; LUNG EMBOLISM; ORTHOPEDIC SURGERY; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ASPIRIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ORTHOPEDIC PROCEDURES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENOUS THROMBOEMBOLISM; VITAMIN K;

EID: 68749106790     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2009.06.002     Document Type: Article

References (28)

1. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 (2004) 338S
2. Callaghan J.J., et al. Prophylaxis for Thromboembolic Disease: Recommendations from the American College of Chest Physicians - Are They Appropriate for Orthopaedic Surgery?. J Arthroplast 20 (2005) 273
3. American College of Chest Physicians. Financial disclosures. Chest 126 (2004) 167S
4. Medicare Quality Improvement Community. Surgical care improvement project (SCIP) VTE prophylaxis options for surgery. [Edited] (2009). www.qualitynet.org
5. American Academy of Orthopaedic Surgeons. American Academy of Orthopaedic Surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. [Edited] (2008). www.aaos.org/Research/guidelines/PE_summary.pdf
6. Haralson R.H. Clearing up the confusion with VTE and/or PE prophylaxis guidelines. AAOS Now (2008) 11 [Edited, 11]
7. Colwell C.W., Collis D.K., Paulson R., et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. J Bone Jt Surg Am 81-A (1999) 932
8. Francis C.W., et al. Prevention of deep-vein thrombosis after total hip arthroplasty. J Bone Jt Surg Am 79-A (1997) 1365
9. Hamulyak K., Lensing A.W.A., van der Meer J., et al. Subcutaneous low-molecular-weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement?. Thromb Haemost 74 (1994) 1428
10. Hull R., et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 329 (1993) 1370
11. Hull R.D., et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double-blind, randomized comparison. Arch Int Med 160 (2000) 2199
12. Lassen M.R., Bauer K.A., Eriksson B.I., et al. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: A randomised double-blind comparison. Lancet 359 (2002) 1715
13. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355 (2000) 1295
14. RD Heparin Arthroplasty Group. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Jt Surg Am 76-A (1994) 1174
15. Turpie A.G.G., Bauer K.A., Eriksson B.I., et al. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: A randomised double-blind trial. Lancet 359 (2002) 1721
16. Bauer K.A., Eriksson B.I., Lassen M.R., et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 345 (2001) 1305
17. Fitzgerald R.H., Spiro T.E., Trowbridge A.A., et al. Prevention of venous thromboembolic disease following primary total knee arthroplasty: A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Jt Surg Am 83-A (2001) 900
18. Heit J.A., Berkowitz S.D., Bona R., et al. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: A double-blind, dose-ranging study. Thromb Haemost 77 (1997) 32
19. Leclerc J.R., et al. Prevention of venous thromboembolism after knee arthroplasty: A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Int Med 124 (1996) 619
20. Eriksson B.I., Bauer K.A., Lassen M.R., et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 345 (2001) 1298
21. O'Donnell M., Linkins L.-A., Kearon C., et al. Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: A systematic review. Arch Int Med 163 (2003) 1362
22. Jadad A.R., Cook D.J., Jones A., et al. Methodology and reports of systematic reviews and meta-analyses: A comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280 (1998) 278
23. Handol H.H.G., Farrar M.J., McBirnie J., et al. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. [Edited]. Cochrane Database Syst Rev (2002)
24. Scottish Intercollegiate Guidelines Network (SIGN). Prevention and Management of Hip Fracture in Older People (2002), SIGN Executive, Royal College of Physicians, Edinburgh 14 [Edited]
25. Fisher C.G., and Wood K.B. Introduction to and techniques of evidence-based medicine. Spine 32 (2007) S66
26. Abramson J. Overdosed America: The Broken Promise of American Medicine (2004), HarperCollins, New York [Edited]
27. Dorr L.D., Gendelman V., Maheshwari A.V., et al. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Jt Surg Am 89-A (2007) 2648
28. Sharrock N.E., Della Valle A.G., Go G., et al. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 466 (2008) 714